Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Polymac Thermoformers Ltd Share Price

₹ 12.35 0.00 (0.00%)

Apr 15 2025 12:00 AM Plastic products NSE: POLYMAC

Polymac Thermoformers Ltd Share Price Update

As of the latest trading session, Polymac Thermoformers Ltd share price is currently at 12.35, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 12.35 and 12.35. Over the past year, Polymac Thermoformers Ltd has achieved a return of -68.56 %. In the last month alone, the return has been -26.30 %. Read More...

Polymac Thermoformers Ltd Performance

Day Range

Low12.35 High12.35

12.35

52 Week Range

Low 11.21 High 46.00

12.35

Polymac Thermoformers Ltd Share Price

537573

POLYMAC

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

12.35 Prev. Close

12.35 Volume (Shares)

800.00 Total traded value

.09

Upper Circuit

12.96 Lower Circuit

11.74

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Polymac Thermoformers Ltd Fundamentals

(Standalone)

Market Cap (Cr)	5.90
PE Ratio (TTM)	20.22
Book Value / Share	22.12
Beta	0.00

ROE	2.92%
EPS (TTM)	0.64
Dividend Yield	0.00%
Net Profit Qtr (Cr)	0.25

Polymac Thermoformers Ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	SEP 2015 (Values in Cr)
Revenue	0.60
Operating Expense	0.00
Net Profit	0.25
Net Profit Margin (%)	41.66
Earnings Per Share (EPS)	0.53
EBITDA	0.00
Effective Tax Rate (%)	0.00

Particulars	JUN 2015 (Values in Cr)
Revenue	0.00
Operating Expense	0.00
Net Profit	-0.98
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	0.00
EBITDA	0.00
Effective Tax Rate (%)	0.00

Particulars	DEC 2014 (Values in Cr)
Revenue	0.00
Operating Expense	0.00
Net Profit	0.31
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	0.64
EBITDA	0.00
Effective Tax Rate (%)	0.00

Particulars	MAR 2014 (Values in Cr)
Revenue	0.36
Operating Expense	0.00
Net Profit	-0.43
Net Profit Margin (%)	-119.44
Earnings Per Share (EPS)	-0.90
EBITDA	0.00
Effective Tax Rate (%)	0.00

Particulars	DEC 2013 (Values in Cr)
Revenue	0.08
Operating Expense	0.00
Net Profit	-0.04
Net Profit Margin (%)	-50.00
Earnings Per Share (EPS)	0.00
EBITDA	0.00
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	14.55
Operating Expense	14.80
Net Profit	0.31
Net Profit Margin (%)	2.13
Earnings Per Share (EPS)	0.64
EBITDA	0.77
Effective Tax Rate (%)	26.19

Particulars	MAR 2023 (Values in Cr)
Revenue	8.80
Operating Expense	10.00
Net Profit	0.45
Net Profit Margin (%)	5.11
Earnings Per Share (EPS)	0.94
EBITDA	0.92
Effective Tax Rate (%)	26.22

Particulars	MAR 2022 (Values in Cr)
Revenue	7.18
Operating Expense	7.59
Net Profit	0.50
Net Profit Margin (%)	6.96
Earnings Per Share (EPS)	1.05
EBITDA	1.03
Effective Tax Rate (%)	23.07

Particulars	MAR 2021 (Values in Cr)
Revenue	6.14
Operating Expense	6.75
Net Profit	0.11
Net Profit Margin (%)	1.79
Earnings Per Share (EPS)	0.23
EBITDA	0.38
Effective Tax Rate (%)	38.88

Particulars	MAR 2020 (Values in Cr)
Revenue	5.24
Operating Expense	6.01
Net Profit	-0.24
Net Profit Margin (%)	-4.58
Earnings Per Share (EPS)	-0.51
EBITDA	0.00
Effective Tax Rate (%)	-13.63

Particulars	MAR 2018 (Values in Cr)
Book Value / Share	21.84
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.10
EBITDA Margin	-1.02

Particulars	MAR 2017 (Values in Cr)
Book Value / Share	22.19
ROE %	1.57
ROCE %	2.44
Total Debt to Total Equity	0.13
EBITDA Margin	15.59

Particulars	MAR 2016 (Values in Cr)
Book Value / Share	22.79
ROE %	0.00
ROCE %	0.41
Total Debt to Total Equity	0.10
EBITDA Margin	13.51

Particulars	MAR 2015 (Values in Cr)
Book Value / Share	21.84
ROE %	0.56
ROCE %	1.10
Total Debt to Total Equity	0.08
EBITDA Margin	19.05

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	22.12
ROE %	2.92
ROCE %	3.92
Total Debt to Total Equity	0.40
EBITDA Margin	5.29

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	21.47
ROE %	4.16
ROCE %	2.62
Total Debt to Total Equity	1.67
EBITDA Margin	10.45

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	23.05
ROE %	4.62
ROCE %	3.47
Total Debt to Total Equity	1.41
EBITDA Margin	14.35

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	22.00
ROE %	1.05
ROCE %	2.51
Total Debt to Total Equity	0.14
EBITDA Margin	6.51

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	21.77
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.12
EBITDA Margin	0.38

Particulars	MAR 2018 (Values in Cr)
Cash & Short Term Investments	1.28
Total Assets	13.04
Total Liabilities	13.04
Total Equity	10.44
Share Outstanding	4781600
Price to Book Ratio	0.00
Return on Assets (%)	-1.31
Return on Capital (%)	-1.55

Particulars	MAR 2017 (Values in Cr)
Cash & Short Term Investments	1.22
Total Assets	15.67
Total Liabilities	15.67
Total Equity	10.61
Share Outstanding	4781600
Price to Book Ratio	1.47
Return on Assets (%)	1.06
Return on Capital (%)	1.39

Particulars	MAR 2016 (Values in Cr)
Cash & Short Term Investments	0.05
Total Assets	14.09
Total Liabilities	14.09
Total Equity	10.89
Share Outstanding	4781600
Price to Book Ratio	0.73
Return on Assets (%)	0.00
Return on Capital (%)	0.01

Particulars	MAR 2015 (Values in Cr)
Cash & Short Term Investments	0.36
Total Assets	13.69
Total Liabilities	13.69
Total Equity	10.44
Share Outstanding	4781600
Price to Book Ratio	1.07
Return on Assets (%)	0.42
Return on Capital (%)	0.52

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	0.09
Total Assets	18.90
Total Liabilities	18.90
Total Equity	10.57
Share Outstanding	4781600
Price to Book Ratio	1.85
Return on Assets (%)	1.62
Return on Capital (%)	2.55

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	6.85
Total Assets	18.26
Total Liabilities	18.26
Total Equity	10.26
Share Outstanding	4781600
Price to Book Ratio	1.58
Return on Assets (%)	2.45
Return on Capital (%)	2.62

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	1.56
Total Assets	40.80
Total Liabilities	40.80
Total Equity	11.01
Share Outstanding	4781600
Price to Book Ratio	1.45
Return on Assets (%)	1.22
Return on Capital (%)	1.26

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	0.18
Total Assets	12.72
Total Liabilities	12.72
Total Equity	10.51
Share Outstanding	4781600
Price to Book Ratio	0.43
Return on Assets (%)	0.86
Return on Capital (%)	0.91

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	0.13
Total Assets	12.33
Total Liabilities	12.33
Total Equity	10.40
Share Outstanding	4781600
Price to Book Ratio	0.00
Return on Assets (%)	-1.97
Return on Capital (%)	-2.09

Particulars	MAR 2024 (Values in Cr)
Net Income	0.41
Cash from Operations	-1.31
Cash from Investing	0.18
Cash from Financing	-5.49
Net change in Cash	-6.75
Free Cash Flow	-0.92

Particulars	MAR 2023 (Values in Cr)
Net Income	0.60
Cash from Operations	25.33
Cash from Investing	1.92
Cash from Financing	-21.97
Net change in Cash	5.28
Free Cash Flow	25.54

Particulars	MAR 2022 (Values in Cr)
Net Income	0.65
Cash from Operations	-25.45
Cash from Investing	-0.03
Cash from Financing	26.90
Net change in Cash	1.38
Free Cash Flow	-24.52

Particulars	MAR 2021 (Values in Cr)
Net Income	0.18
Cash from Operations	-0.51
Cash from Investing	0.45
Cash from Financing	0.19
Net change in Cash	0.04
Free Cash Flow	-0.41

Particulars	MAR 2020 (Values in Cr)
Net Income	-0.21
Cash from Operations	0.67
Cash from Investing	-0.68
Cash from Financing	-0.10
Net change in Cash	-0.14
Free Cash Flow	0.94

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
CAPRIHANS INDIA LTD.	131.15	0.00	0.43	191.79	115.00 / 194.75
SUPREME INDUSTRIES LTD	3169.50	39.40	7.58	40261.17	3020.00 / 6482.40
SAFARI IND (INDIA) LTD	2090.50	68.86	11.46	10219.73	1781.00 / 2837.20
VIP INDUSTRIES LTD	266.75	0.00	5.84	3788.38	248.55 / 589.95
JAIN IRRIGATION SYSTEMS	52.27	79.20	0.64	3566.49	49.01 / 84.10

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
CAPRIHANS INDIA LTD.	131.15	0.00	-1.08	191.79	115.00 / 194.75
GUJARAT PETROSYNTHESE LTD.	57.18	31.08	0.69	34.13	52.10 / 97.96
SUPREME INDUSTRIES LTD	3169.50	42.40	8.61	40261.17	3020.00 / 6482.40
SAFARI IND (INDIA) LTD	2090.50	83.15	12.04	10219.73	1781.00 / 2837.20

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 13.20
26 Days 14.80
10 Days 13.30
50 Days 17.00
12 Days 13.40
100 Days 21.20
20 Days 14.20
200 Days 26.60

12.94
PIVOT

First Resistance	12.94
Second Resistance	12.94
Third Resistance	12.94

First Support	12.94
Second Support	12.94
Third Support	12.94

RSI	35.26
MACD	-1.41
Commodity Channel Index (CCI)	-47.36

ADX	47.66
Williams % R	-44.90

Polymac Thermoformers Ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

74.79 Promoter Holdings

25.2 FII

0.0 DII

0.0 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Puspjeet Kumar	Shareholding of Promoter and Promoter Group	934950.0	19.55
Yaduka Coaching Centre Private Limited	Shareholding of Promoter and Promoter Group	270350.0	5.65
Prince Mercantile Private Limited	Public Shareholding	225000.0	4.71
Shivam Vincom Private Limited	Public Shareholding	225000.0	4.71
Vindhywasini Vanijya Llp	Public Shareholding	220000.0	4.6
Evernew Dealcom Llp .	Public Shareholding	207200.0	4.33
Parijat Tradecom Private Limited	Public Shareholding	176500.0	3.69
Aditya Apoorva	Public Shareholding	162400.0	3.4
Champaben Jivabhai Patel	Public Shareholding	120000.0	2.51
Jivabhai Ambalal Patel	Public Shareholding	120000.0	2.51
Rinku Goenka	Public Shareholding	103200.0	2.16
Rishu Kumari	Public Shareholding	84800.0	1.77
Ishita Rani Goenka	Public Shareholding	84000.0	1.76
Rajesh Goenka	Public Shareholding	78400.0	1.64
Ritesh Jivabhai Patel	Public Shareholding	60000.0	1.25
Anjali	Public Shareholding	50000.0	1.05
Vipin Kumar	Public Shareholding	50000.0	1.05

Polymac Thermoformers Ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read